IP Library Granted Patent US 9,333,267
Granted Patent B2
US 9,333,267 · App. 14/694,160 · Granted May 10, 2016

Thiol-selective water-soluble polymer derivatives

Inventors: Antoni Kozlowski (Huntsville, AL); Remy F. Gross, III (Petaluma, CA); Samuel P. McManus (Guntersville, AL)
Assignee: Nektar Therapeutics
A61K47/48215A61K47/48238C07C319/06C07C323/41C08G65/00C08G65/2636C08G65/329C08G65/334C08L2203/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,267
App. No.
14/694,160
Granted
May 10, 2016
Kind
B2
Abstract

The present invention provides water-soluble, polymer derivatives having a thiol-selective terminus suitable for selective coupling to thiol groups, such as those contained in the cysteine residues of proteins.

Claims (35)

1. A method for preparing a thiol-selective derivative of a water-soluble polymer comprising the steps of:

(i) providing an electrophilically-activated polymer, POLY-L 0,1 -E, wherein:

POLY is a water-soluble polymer segment,

L is an optional linker,

E is an electrophile, and

(ii) reacting the POLY-L 0,1 -E with a symmetrical disulfide reagent, (NU-Y-S-) 2 , wherein:

NU is a nucleophile, and

Y is alkylene, substituted alkylene, cycloalkylene, substituted cycloalkylene, aryl, or substituted aryl, comprising from about 2 to about 10 carbon atoms,

under conditions effective to promote reaction between E and NU to thereby form POLY-L 0,1 -X-Y-S-S-Y-X-L 0,1 -POLY, wherein X is a group resulting from the reaction between E and NU.

2. The method of claim 1 , further comprising the step of (iii) reducing the disulfide bond in POLY-L 0,1 -X-Y-S-S-Y-X-L 0,1 -POLY to form POLY-L 0,1 -X-Y-SH.

3. The method of claim 1 , wherein L 1 is C 1 -C 10 alkylene or C 1 -C 10 substituted alkylene.

4. The method of claim 3 , wherein L 1 is—(CH 2 ) 1-5 —.

5. The method of claim 1 , wherein E is a carboxylic acid or an activated carboxylic acid derivative.

6. The method of claim 1 , wherein E is a carboxylic acid, activated carboxylic acid ester, acid halide, or active anhydride.

7. The method of claim 6 , wherein E is an N-hydroxysuccinimidyl ester.

8. The method of claim 1 , wherein NU is amino, hydroxy, imino, or thiol.

9. The method of claim 1 , wherein NU is —NH 2 .

10. The method of claim 1 , wherein X is an amide, carbamate, carbonate ester, ether, or thioester.

11. The method of claim 1 , wherein POLY is a polyalkylene oxide.

12. The method of claim 11 , wherein POLY is a polyethylene glycol having the structure H 3 CO—(CH 2 CH 2 O) n CH 2 CH 2 — wherein n ranges from 10 to about 4,000.

13. The method of claim 11 , wherein POLY is end-capped.

14. The method of claim 12 , wherein L is absent or —CH 2 —, and E is N-hydroxysuccinimidyl ester or 1-hydroxybenzotriazolyl carbonate.

15. The method of claim 14 , wherein the symmetrical disulfide reagent is cystamine, where NU is primary amino and Y is —(CH 2 ) 2 —.

16. A method for preparing a polymer-protein conjugate comprising the steps of:

(i) providing an electrophilically-activated polymer, POLY-L 0,1 -E, wherein:

POLY is a water-soluble polymer segment,

L is an optional linker, and

E is an electrophile,

(ii) reacting the POLY-L 0,1 -E with a symmetrical disulfide reagent, (NU-Y-S-) 2 , wherein:

NU is a nucleophile, and

Y is selected from the group consisting of C 2 -C 10 alkylene, C 2 -C 10 substituted alkylene, arylene, and substituted arylene,

under conditions effective to promote reaction between E and NU to thereby form POLY-L 0,1 -X-Y-S-S-Y-X-L 0,1 -POLY wherein X is a group resulting from the reaction between E and NU,

(iii) reducing the disulfide bond in POLY-L 0,1 -X-Y-S-S-Y-X-L 0,1 -POLY to form POLY-L 0,1 -X-Y-SH, and

(iv) reacting POLY-L 0,1 -X-Y-SH with a thiol or protected thiol group of a protein to form a protein conjugate, POLY-L 0,1 -X-Y-S-S-protein.

17. The method of claim 16 , wherein the protein is a therapeutic protein.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
SECURITY INTEREST Recorded Jul 8, 2016
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 039111/0745 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 35767, FRAME 0695 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036855/0686 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
SECURITY INTEREST Recorded Jun 2, 2015
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 035767/0695 →
Continuity (7)
Continuation 14229547 · Mar 28, 2014
Continuation 13681357 · Nov 19, 2012
Continuation 12909755 · Oct 21, 2010
Continuation 10753047 · Jan 6, 2004
Provisional Application 60455084 · Mar 14, 2003
Provisional Application 60438555 · Jan 6, 2003
Related Publication 20150224207A1 · Aug 13, 2015